FDA License Awarded for Manufacture of the Orlucent Fluorescent Molecular Imaging System for Suspicious Moles

Los Gatos, CA, March 9, 2021 – Orlucent meets the requirements for a California Food and Drug Branch Manufacturing License, which demonstrates they are registered with the FDA as a manufacturing site and meet the standards of the FDA and the State of California.